A

AptaBio Therapeutics Inc
KOSDAQ:293780

Watchlist Manager
AptaBio Therapeutics Inc
KOSDAQ:293780
Watchlist
Price: 9 250 KRW 0.33% Market Closed
Market Cap: 248.6B KRW

Wall Street
Price Targets

Price Targets Summary
AptaBio Therapeutics Inc

There are no price targets for AptaBio Therapeutics Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
AptaBio Therapeutics Inc Competitors:
Price Targets
2696
Shanghai Henlius Biotech Inc
69% Upside
301080
Acrobiosystems Co Ltd
39% Upside
002007
Hualan Biological Engineering Inc
25% Upside
302440
SK Bioscience Co Ltd
20% Downside
CELC
Celcuity Inc
10% Upside
VCEL
Vericel Corp
49% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
HALO
Halozyme Therapeutics Inc
13% Upside

Revenue
Forecast

Revenue Estimate
AptaBio Therapeutics Inc

For the last 6 years the compound annual growth rate for AptaBio Therapeutics Inc's revenue is 15%. The projected CAGR for the next 5 years is -21%.

15%
Past Growth
-21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
AptaBio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
AptaBio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AptaBio Therapeutics Inc's stock price target?
Not Available

AptaBio Therapeutics Inc doesn't have any price targets made by Wall Street professionals.

What is AptaBio Therapeutics Inc's Revenue forecast?
Projected CAGR
-21%

For the last 6 years the compound annual growth rate for AptaBio Therapeutics Inc's revenue is 15%. The projected CAGR for the next 5 years is -21%.

Back to Top